Carbon monoxide induced PPARγ SUMOylation and UCP2 block inflammatory gene expression in macrophages

Arvand Haschemi1, Beek Yoke Chin, Markus Jeitler

  • 1Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Plos One
|November 3, 2011
PubMed

Insights

Carbon monoxide (CO) reduces inflammation by activating p38 MAPK and enhancing PPARγ SUMOylation, a process involving mitochondrial ROS and UCP2. This mechanism suppresses the pro-inflammatory Egr-1 in macrophages.

Area of Science:

  • Biochemistry
  • Immunology
  • Molecular Biology

Background:

  • Carbon monoxide (CO) is known to suppress inflammatory responses.
  • CO's anti-inflammatory effects are partly mediated by peroxisome proliferator-activated receptor-γ (PPARγ) and p38 mitogen-activated protein kinase (MAPK).
  • Previous studies showed CO inhibits lipopolysaccharide (LPS)-induced early growth response-1 (Egr-1) via PPARγ activation.

Purpose of the Study:

  • To elucidate the detailed molecular mechanisms underlying CO's modulation of PPARγ activity and Egr-1 repression.
  • To investigate the roles of PPARγ SUMOylation, p38 MAPK activation, and mitochondrial reactive oxygen species (ROS) in CO's anti-inflammatory effects.

Main Methods:

  • Investigated CO's effect on PPARγ SUMOylation using mutant PPARγ constructs.
  • Assessed the impact of blocking PPARγ SUMOylation and p38 MAPK activation on LPS-induced Egr-1 expression.
  • Utilized primary macrophages from wild-type and Ucp2 gene Knock-Out mice to examine the role of mitochondrial ROS and UCP2.

Main Results:

  • CO enhances PPARγ SUMOylation, which is linked to mitochondrial ROS generation.
  • CO-activated p38 MAPK also contributes to Egr-1 repression.
  • Blocking both PPARγ SUMOylation and p38 activation fully reversed CO's anti-inflammatory effects.
  • Mitochondrial ROS, triggered by CO partly via uncoupling protein 2 (UCP2), are crucial for Egr-1 repression.
  • Absence of UCP2 abolished CO-mediated Egr-1 repression in macrophages.

Conclusions:

  • CO exerts anti-inflammatory effects through a cooperative system involving p38 MAPK activation, PPARγ SUMOylation, and ROS formation via UCP2.
  • This pathway effectively dampens the inflammatory response by repressing Egr-1 expression in macrophages.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...